Colour photographs for screening in neovascular age-related macular degeneration: are they necessary?

Colour photographs for screening in neovascular age-related macular degeneration: are they necessary?

AIMS: To investigate whether optical coherence tomography (OCT) with associated infra-red images provide enough information to determine treatment decisions in the management of neovascular age-related macular degeneration (nAMD), or whether retinal colour photography is also necessary. METHODS: In...

Full description

Bibliographic Details
Main Authors:	Hibbs, S, Smith, A, Chow, L, Downes, S
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Radiotherapy for neovascular age-related macular degeneration.
by: Evans, JR, et al.
Published: (2010)

Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
by: Chakravarthy, U, et al.
Published: (2012)

Optical coherence tomography in neovascular age-related macular degeneration
by: Chong, V
Published: (2012)

Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data
by: Spaide, Richard F., et al.
Published: (2021)

Screening for age-related macular degeneration using nonstereo digital fundus photographs.
by: Jain, S, et al.
Published: (2006)

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
by: Morohoshi, K, et al.
Published: (2012)

Quality of fixation in eyes with neovascular age-related macular degeneration treated with ranibizumab.
by: Sivaprasad, S, et al.
Published: (2011)

Evolving European guidance on the medical management of neovascular age related macular degeneration.
by: Chakravarthy, U, et al.
Published: (2006)

Treat-And-extend bevacizumab for neovascular age-related macular degeneration: The importance of baseline characteristics
by: Rush, R, et al.
Published: (2014)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
by: von der Emde, L, et al.
Published: (2019)

Quantitative Optical Coherence Tomography Angiography of Choroidal Neovascularization in Age-Related Macular Degeneration
by: Jia, Yali, et al.
Published: (2015)

Autologous transplantation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2007)

Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Pharmacogenetic Associations with Vascular Endothelial Growth Factor Inhibition in Participants with Neovascular Age-Related Macular Degeneration in the IVAN Study
by: Lotery, A, et al.
Published: (2013)

Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the ivan study
by: Lotery, A, et al.
Published: (2013)

Deliberations of an International Panel of Experts on OCT Angiography Nomenclature of Neovascular Age-Related Macular Degeneration
by: Mendonça, Luísa SM, et al.
Published: (2022)

Second eye of patients with unilateral neovascular age-related macular degeneration: Caucasians vs Chinese.
by: Sivaprasad, S, et al.
Published: (2006)

Deficient RPE mitochondrial energetics leads to subretinal fibrosis in age-related neovascular macular degeneration
by: Ma, X, et al.
Published: (2024)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
by: Chakravarthy, U, et al.
Published: (2012)

Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: One-year findings from the IVAN randomized trial
by: Chakravarthy, U, et al.
Published: (2012)

Long-term results of submacular surgery combined with macular translocation of the retinal pigment epithelium in neovascular age-related macular degeneration.
by: Maclaren, R, et al.
Published: (2005)

Type 1 choroidal neovascularization is associated with reduced localized progression of atrophy in age-related macular degeneration
by: Pfau, M, et al.
Published: (2019)

Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.
by: Pearce, E, et al.
Published: (2011)

Long-Term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with Ranibizumab
by: Menke, Marcel N., et al.
Published: (2013)

rs10737680 polymorphism in complement factor H and neovascular age-related macular degeneration in Yogyakarta, Indonesia
by: Sigalingging, Talenta, et al.
Published: (2022)

Association of the HtrA1 rs11200638 Polymorphism with Neovascular Age-Related Macular Degeneration in Indonesia
by: Supanji, Supanji, et al.
Published: (2021)

Image mining approaches for the screening of age-related macular degeneration
by: Mohd Hanafi Ahmad Hijazi, et al.
Published: (2012)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Intravitreal aflibercept injection for neovascular age-related macular degeneration: Ninety-six-week results of the VIEW studies
by: Schmidt-Erfurth, U, et al.
Published: (2014)

Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study
by: Hernandez, R, et al.
Published: (2021)

Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
by: Saleh, Rafidah, et al.
Published: (2017)

Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
by: Borchert, GA, et al.
Published: (2024)

Gene therapy for age-related macular degeneration
by: MacLaren, RE
Published: (2015)

The complement system and age-related macular degeneration.
by: Sivaprasad, S, et al.
Published: (2006)

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
by: Ross, A, et al.
Published: (2013)

Long-term visual and microperimetry outcomes following autologous retinal pigment epithelium choroid graft for neovascular age-related macular degeneration.
by: Chen, F, et al.
Published: (2009)

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
by: Borchert, GA, et al.
Published: (2024)

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
by: Jackson, TL, et al.
Published: (2024)

Systemic complement activation in age-related macular degeneration.
by: Scholl, H, et al.
Published: (2008)

Choriocapillaris Loss in Advanced Age-Related Macular Degeneration
by: Moreira-Neto, Carlos A., et al.
Published: (2018)